UFLEX Limited has informed the Exchange about Presentation
UFLEX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
UFLEX Limited held an earnings conference call on May 20, 2025, sharing its Q4 FY25 results presentation. FY25 consolidated revenue grew 12.4% YoY to Rs. 151,838 million, with Normalized EBITDA up 18.1% YoY at Rs. 19,024 million and margin expanding 60bps to 12.5%. Q4 FY25 revenue rose 10.8% YoY to Rs. 38,738 million, but Normalized EBITDA margin contracted 150bps QoQ to 12.3% on pricing pressure. The company is investing in major capex projects — an aseptic packaging plant in Egypt (USD 126M), a WPP plant in Mexico for pet food (USD 50M), recycling plants in India (Rs. 3,171M), and an Asepto debottlenecking — with commissioning targeted in FY26. Net debt rose to Rs. 68,432 million, pushing Net Debt/EBITDA to 3.60x from 3.46x a year ago.
Mixed Q4 — topline growth was healthy but quarterly margins slipped and debt continues to climb, which may temper near-term investor enthusiasm. The strong FY26 outlook from management, global capacity expansion into Egypt and Mexico, and stated intent to deleverage through new project cash flows offer a constructive medium-term setup, but execution and currency headwinds in Nigeria, Mexico and Egypt remain key risks.